Zoledronic Acid in Children (1 -17 Years) With Severe Osteogenesis Imperfecta

Summary

This is an extension study to examine the long-term safety and efficacy of zoledronic acid in patients who have completed the core CZOL446H2202 study.

Timeline

Start

2004-07

Primary completion

2007-05

Completion

2007-05

Drugs

Indications